Journal
NEUROTHERAPEUTICS
Volume 11, Issue 4, Pages 732-737Publisher
SPRINGER
DOI: 10.1007/s13311-014-0295-9
Keywords
Alzheimer's disease; Genetics; Next generation sequencing; Genome-wide association studies
Funding
- Medical Research Council [MC_G1000735] Funding Source: Medline
- Wellcome Trust [089698] Funding Source: Medline
- MRC [MC_G1000735] Funding Source: UKRI
- Alzheimers Research UK [ARUK-TRFUS2012-3] Funding Source: researchfish
- Medical Research Council [MC_G1000735] Funding Source: researchfish
Ask authors/readers for more resources
The analyses of genetic factors contributing to Alzheimer's disease (AD) and other dementias have evolved at the same pace as genetic and genomic technologies are developed and improved. The identification of the first genes involved in AD arose from family-based studies, but risk factors have mainly been identified by studies comparing groups of patients with groups of controls. The best outcomes have been heavily associated with the capacity of interrogating genetic variability at the genome level without any particular a priori hypothesis. In this review we assess the role of genetic family studies in Alzheimer's disease and other dementias within the current status of dementias' and, particularly, AD's genetic architecture.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available